Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

   40,287,245      
Direct Value   $128,455,406    

Indirect Value

   $40,265,984      
Total Shares   87,362,343      
Total Value   $168,721,391      


Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407 Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    99   
    96    

     Stock price went up :
    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 24 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-11-25 4 B $2.39 $35,850 D/D 15,000 30,114,285 3.92 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-11-24 4 B $2.40 $114,559 D/D 47,733 30,099,285 3.92 %
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2021-08-02 4 S $2.40 $463,046 I/I (192,775) 785,000 0 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-03-27 4 B $2.43 $87,480 I/I 36,000 752,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-06-11 4 B $2.44 $68,320 I/I 28,000 1,128,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-12-03 4 B $2.44 $48,800 D/D 20,000 30,134,285 3.92 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-03-20 4 B $2.50 $24,065 I/I 9,626 714,626 2.17 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-06-09 4 B $2.50 $4,384,200 D/D 1,753,680 29,914,285 3.92 %
VXRT Vaxart Inc Director   –       •       •   2020-05-07 4 S $2.51 $251,000 D/D (100,000) 15,800,000 0 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-03-23 4 B $2.52 $3,462 I/I 1,374 716,000 2.17 %
VXRT Vaxart Inc Director   –       •       •   2020-05-08 4 S $2.52 $252,000 D/D (100,000) 15,700,000 0 %
ACHV Achieve Life Sciences Inc 10% Owner   –       –       •   2019-06-11 4 S $2.53 $837,467 D/D (264,963) 843,776 0 -
VXRT Vaxart Inc Director   –       •       •   2020-05-06 4 S $2.58 $129,000 D/D (50,000) 15,900,000 0 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-03-19 4 B $2.60 $4,074 I/I 1,567 705,000 2.17 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2021-01-08 4 B $2.60 $6,500,000 D/D 2,500,000 32,634,285 3.92 %
VXRT Vaxart Inc Director   –       •       •   2020-05-27 4 S $2.61 $522,000 D/D (200,000) 8,400,000 0 %
VXRT Vaxart Inc Director   –       •       •   2020-05-04 4 S $2.65 $2,537,293 D/D (957,469) 16,642,531 0 %
BPTH Bio-Path Holdings, Inc. 10% Owner   –       –       •   2019-01-18 4 S $2.66 $171,643 D/D (64,457) 129,298 0 -
VXRT Vaxart Inc Director   –       •       •   2020-05-05 4 S $2.66 $1,842,132 D/D (692,531) 15,950,000 0 %
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2021-07-30 4 S $2.69 $183,562 I/I (68,188) 977,775 0 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2021-08-04 4 B $2.69 $268,590 I/I 100,000 39,200,000 1.5 %
VXRT Vaxart Inc Director   –       •       •   2020-05-01 4 S $2.71 $2,710,000 D/D (1,000,000) 17,600,000 0 %
VXRT Vaxart Inc Director   –       •      –    2020-06-01 4 S $2.74 $548,000 D/D (200,000) 8,200,000 0 %
VXRT Vaxart Inc Director   –       •      –    2020-06-02 4 S $2.75 $2,200,000 D/D (800,000) 7,400,000 0 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2021-08-16 4 B $2.75 $82,638 I/I 30,000 39,280,000 2.25 %
  790  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24  25   26   27   28   29   30   31   32      
  Page 24 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us